Parc de Salut Mar

Parc de Salut Mar is a public hospital consortium in Barcelona, Spain, whose research arm IMIM (Hospital del Mar Medical Research Institute) has conducted controlled human pharmacology studies of MDMA and novel psychoactive substances. Their Integrative Pharmacology and Systems Neuroscience Research Group ran landmark double-blind crossover trials comparing mephedrone to MDMA in healthy volunteers and investigating MDMA pharmacokinetics by sex and CYP2D6 genotype.